Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
スポンサーリンク
概要
著者
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
UENO Hideki
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Matsuno Yoshihiro
Clinical Laboratory Division National Cancer Center Hospital
-
Kobayashi Y
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
MURAKAMI Jun
Hematology Division, National Cancer Center Hospital
-
FUKUSHIMA Noriyoshi
Clinical Laboratory Division, National Cancer Center Hospital
-
SAITO Takeshi
Hematology Division, National Cancer Center Hospital
-
TANOSAKI Ryuji
Hematology Division, National Cancer Center Hospital
-
Tanosaki R
Division Of Hematology And Hematopoietic Stem Cell Transplantation National Cancer Center Hospital
-
Tanosaki Ryuji
国立がんセンター中央病院 造血幹細胞移植グループ
-
Tanosaki Ryuji
Hematopoietic Stem Cell Transplantation Unit National Cancer Center Hospital
-
Fukushima Noriyoshi
Clinical Laboratory Division National Cancer Center Hospital
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
WATANABE Toru
National Cancer Center Hospital
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Ryuji Tamura
Department Of Materials Science And Technology Science University Of Tokyo
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Kobayashi Yukio
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Kobayashi Masayuki
Hematology Division National Cancer Center Hospital
-
Watanabe T
Tokyo Univ. Tokyo
-
Watanabe T
Hematology Division National Cancer Center Hospital
-
Ueno Hideki
Hepatobiliary And Pancreatic Oncology Division National Cancer Center Hospital
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Watanabe T
Department Of Pathology Gifu University School Of Medicine
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Tanosaki Ryuji
Hematopoietic Stem Cell Transplantation Division National Cancer Center Hospital
-
Yano Kunio
県西部浜松医療センター
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Ueno Hideki
Hepatobiliary And Pancreatic Oncology Division
-
Murakami Jun
Hematology Division National Cancer Center Hospital
-
Watanabe Toru
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Functional MRI : Principles and Applications to the Visual System
- Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C
- Dose-response Trial of Lactoferrin in Patients with Chronic Hepatitis C
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
- Abdominal Pain in Patients with Resectable Pancreatic Cancer with Reference to Clinicopathologic Findings
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer : a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications
- Spontaneous regression of hepatocellular carcinoma
- The Usefulness of Serial Changes in Serum CA19-9 Levels in the Diagnosis of Pancreatic Cancer
- Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
- Treatment of Indolent Non-Hodgkin's Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone
- Proteasome inhibitor, bortezomib, for myeloma and lymphoma
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Detection of Two Cell Populations Corresponding to Distinct Maturation Stages in API-2/MLT-Positive Mucosa-Associated Lymphoid Tissue Lymphoma Cells Proliferating in Pleural Effusion
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
- Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
- Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
- Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors